Arcturus Therapeutics
ARCT
$26.63
Share price
0.30%
Change (1 day)
1.95%
Change (1 year)
EPS for Arcturus Therapeutics (ARCT)
EPS in 2023 (TTM): $3.03
According to Arcturus Therapeutics 's latest financial reports the company's current EPS (TTM) is $3.03. In 2022 the company made an earnings per share (EPS) of $0.34 an increase over its 2021 EPS that were of -$7.74.
EPS history for Arcturus Therapeutics from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $3.03 | 791.18% |
| 2022 | $0.34 | -104.39% |
| 2021 | -$7.74 | 121.14% |
| 2020 | -$3.50 | 69.08% |
| 2019 | -$2.07 | -4.17% |
| 2018 | -$2.16 | -37.49% |
| 2017 | -$3.46 | -44.53% |
| 2016 | -$6.23 | -1.11% |
| 2015 | -$6.30 | -62.66% |
| 2014 | -$16.87 | 163.71% |
| 2013 | -$6.40 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$0.06000 | -101.98% | Bahamas |
 NRC Health
NRC | $1.19 | -60.73% | 🇺🇸 USA |